The Effect of Polymorphisms in Candidate Genes on the Long-Term Risk of Lipodystrophy and Dyslipidemia in HIV-Infected White Patients Starting Antiretroviral Therapy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  2011-11-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/aid.2010.0172PMID 21595566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study

  2010cited by this paper
• Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Adiponectin and Leptin Levels in Chinese Patients with HIV-Related Lipodystrophy: A 30-Month Prospective Study

  2009cited by this paper
• Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals: A Longitudinal Study

  2009cited by this paper
• Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy

  2008influential reference
• Drug-Specific Effect of Nelfinavir and Stavudine on Primary Culture of Human Preadipocytes

  2008cited by this paper
• Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes

  2008cited by this paper
• High-Density Lipoprotein Cholesterol in HIV-Infected Patients: Evidence for an Association with HIV-1 Viral Load, Antiretroviral Therapy Status, and Regimen Composition

  2008cited by this paper
• Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.

  2007cited by this paper
• Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy

  2007cited by this paper
• The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians

  2006cited by this paper
• Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls

  2006cited by this paper
• Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy

  2006cited by this paper
• Quality of Life and Body Image in the Assessment of Psychological Impact of Lipodystrophy: Validation of the Italian Version of Assessment of Body Change and Distress Questionnaire

  2006cited by this paper
• Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.

  2006cited by this paper
• Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.

  2006cited by this paper
• Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study

  2006cited by this paper
• Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.

  2006cited by this paper
• Association of the 276G->T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans.

  2005cited by this paper
• Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral‐naïve cohort

  2005cited by this paper
• Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection.

  2005cited by this paper
• The efavirenz-induced increase in HDL-cholesterol is influenced by the multidrug resistance gene 1 C3435T polymorphism

  2005cited by this paper
• Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy

  2005cited by this paper
• Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.

  2005cited by this paper
• Evaluation of the HIV Lipodystrophy Case Definition in a Placebo-Controlled, 144-Week Study in Antiretroviral-Naive Adults

  2005cited by this paper
• Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients

  2004cited by this paper
• The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption.

  2004cited by this paper
• Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease

  2004cited by this paper
• Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1.

  2004cited by this paper
• Tolerability and Safety of HIV Protease Inhibitors in Adults

  2004cited by this paper
• Detection of genotyping errors by Hardy–Weinberg equilibrium testing

  2004cited by this paper
• Genotyping for cytokine polymorphisms: allele frequencies in the Italian population.

  2003cited by this paper
• Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy

  2003cited by this paper
• Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies.

  2003cited by this paper
• Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men

  2003cited by this paper
• Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy

  2003cited by this paper
• HIV lipodystrophy: prevalence, severity and correlates of risk in Australia

  2003cited by this paper
• Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy.

  2003cited by this paper
• Combination antiretroviral therapy and the risk of myocardial infarction.

  2003cited by this paper
• No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment.

  2003cited by this paper
• Gender Differences in Antiretroviral Drug–Related Adipose Tissue Alterations: Women Are at Higher Risk Than Men and Develop Particular Lipodystrophy Patterns

  2003cited by this paper
• TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.

  2002cited by this paper
• Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

  2002cited by this paper
• Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes.

  2002cited by this paper
• Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.

  2002cited by this paper
• A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.

  2002cited by this paper
• TNF-α promoter region gene polymorphisms in HIV-positive patients with lipodystrophy

  2002cited by this paper
• Relationship Between HAART Adherence and Adipose Tissue Alterations

  2002cited by this paper
• Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database

  2001cited by this paper
• MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.

  2001cited by this paper
• Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

  2001cited by this paper
• Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport

  2001cited by this paper
• An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients

  2001cited by this paper
• Genomic structure and mutations in adipose-specific gene, adiponectin

  2000cited by this paper
• The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis

  2000cited by this paper
• Apolipoprotein E: far more than a lipid transport protein.

  2000cited by this paper
• Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

  2000cited by this paper
• Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine.

  2000influential reference
• ApoE genotype and protease-inhibitor-associated hyperlipidaemia.

  1999cited by this paper
• The role of TNF alpha in adipocyte metabolism.

  1999cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.

  1998cited by this paper
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

  1995cited by this paper
• Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.

  1990cited by this paper
• Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

  1989cited by this paper

• The influence of socioeconomic factors and apolipoprotein ε genotype on cognitive outcomes in a multi-ethnic sample living with HCV and HIV

  2025cites this paper
• Correlation of APOE polymorphism, expression, and plasma levels with cardiac comorbidities among lipodystrophy in HIV-infected patients.

  2024cites this paper
• Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV‐associated lipodystrophy

  2023influential citation
• Impact of inflammatory cytokine and adipokine gene variations in the development of HIV‐associated lipodystrophy

  2023cites this paper
• LIPOPROTEIN LIPASE GENE POLYMORPHISM – CORRELATION WITH SERUM TRIGLYCERIDES LEVELS

  2019cites this paper
• Pharmacogenetic considerations in the treatment of HIV.

  2017cites this paper
• Deciphering the molecular mechanisms involved in HIV-associated lipoatrophy by transcriptomics: a pilot study

  2016cites this paper
• Effect of adiponectin-encoding gene ADIPOQ single nucleotide polymorphisms +45 and +276 on serum lipid levels after antiretroviral therapy in Japanese patients with HIV-1-infection

  2016cites this paper
• Role of 3 Lipoprotein Lipase Variants in Triglycerides in Children Receiving Highly Active Antiretroviral Therapy

  2015cites this paper
• Polymorphisms of the ApoE (Apolipoprotein E) gene and their influence on dyslipidemia in HIV-1-infected individuals.

  2015influential citation
• Cardiac morbidity in an HIV-1 lipodystrophy patient cohort expressing the TNF-α-238 G/A single nucleotide gene polymorphism.

  2015cites this paper
• Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome

  2015cites this paper
• High Producer Haplotype (CAG) of -863C/A, -308G/A and -238G/A Polymorphisms in the Promoter Region of TNF-α Gene Associate with Enhanced Apoptosis of Lymphocytes in HIV-1 Subtype C Infected Individuals from North India

  2014cites this paper
• Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults.

  2014cites this paper
• Antiretroviral therapy and genetic predisposition: Cofactors contributing to the lipodystrophy syndrome

  2014cites this paper
• Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART

  2013cites this paper
• HAART-Associated Dyslipidemia Varies by Biogeographical Ancestry in the Multicenter AIDS Cohort Study

  2013influential citation
• antiretroviral therapy in resource-limited settings: adapting

  2012cites this paper
• Polymorphisms in Candidate Genes and Lipodystrophy and Dyslipidemia

  2012cites this paper
• Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy.

  2012cites this paper
• Relationship Between Plasma Protease Inhibitor Concentrations and Lipid Elevations in HIV Patients on a Double‐Boosted Protease Inhibitor Regimen (Saquinavir/Lopinavir/Ritonavir)

  2010cites this paper
• Current World Literature

  2003cites this paper